新的HLA-DRB1*12:113等位基因通过下一代测序被确定
Min-Kyung So1, Youn Keong Cho1, Sori Lim2
1Department of Laboratory Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
HLA
|July 17, 2025
概括
人类白细胞抗原 (HLA) DRB1*12:113基因基因与HLA-DRB1*12:01:01:14基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因. 这些遗传变异对于理解HLA多样性很重要.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 人类遗传学 人类遗传学
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应和移植中起着至关重要的作用.
- 特定的HLA等位基因与各种自身免疫性疾病和药物过敏症有关.
- 对新型HLA等位基因的准确表征对于HLA类型和种群遗传学至关重要.
研究的目的:
- 报告和描述一个新发现的HLA-DRB1等位基因,指定HLA-DRB1*12:113.
- 为了将新型等位基因与已知的相关HLA-DRB1等位基因进行比较.
- 识别特定的核酸和氨基酸差异,有助于新的等位基因.
主要方法:
- 使用下一代测序 (NGS) 进行了高分辨率的HLA类型识别.
- 进行了序列分析以确定核酸变异.
- 与IMGT/HLA数据库对比新的序列.
主要成果:
- 一个新的HLA-DRB1等位基因,HLA-DRB1*12:113,被确定.
- 这种等位基因与HLA-DRB1*12:01:01:14有两个单核酸多态 (SNPs) 在代95 (GTC>ATC) 和代191 (CGG>TGG).
- 这些核酸变化导致95位和191位的氨基酸替代.
结论:
- 鉴定HLA-DRB1*12:113扩大了已知的HLA-DRB1等位基因的范围.
- 具体的序列差异突出显示了HLA基因内的持续演变和多样性.
- 这种详细的表征有助于精确的HLA类型和了解免疫系统变异.
相关概念视频
Next-generation Sequencing
87.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.9K
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K


